Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
Cytokine-induced killer (CIK) cells, a heterogeneous T cell population obtained by in vitro differentiation of peripheral blood mononuclear cells (PBMC), represent a promising immunological approach in cancer. Numerous studies have explored the role of CD38, CD39, CD203a/PC-1, and CD73 in generating...
Saved in:
Main Authors: | Alberto L. Horenstein (Author), Antonella Chillemi (Author), Roberta Zini (Author), Valeria Quarona (Author), Nicoletta Bianchi (Author), Rossella Manfredini (Author), Roberto Gambari (Author), Fabio Malavasi (Author), Davide Ferrari (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
by: Ana Maria Oliveira Battastini, et al.
Published: (2021) -
Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
by: Carla Fernanda Furtado Gardani, et al.
Published: (2023) -
Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
by: Laura Schäkel, et al.
Published: (2020) -
High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
by: Elisabet Aliagas, et al.
Published: (2014) -
Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule
by: Antonella Chillemi, et al.
Published: (2013)